Pursuant to Regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that it enclosed the schedule of Earnings Call to be held on November 6, 2025 at 8:30 am (IST) on Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2025.
The above information is a part of company’s filings submitted to BSE.